ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 128 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $58,000 | -20.5% | 1,735 | -36.8% | 0.00% | -50.0% |
| Q3 2016 | $73,000 | -6.4% | 2,745 | -23.0% | 0.00% | 0.0% |
| Q2 2016 | $78,000 | -36.1% | 3,564 | -14.6% | 0.00% | -50.0% |
| Q1 2016 | $122,000 | -60.8% | 4,175 | -55.7% | 0.00% | -60.0% |
| Q4 2015 | $311,000 | -11.6% | 9,431 | -3.4% | 0.01% | -16.7% |
| Q3 2015 | $352,000 | – | 9,758 | +57300.0% | 0.01% | – |
| Q2 2015 | $0 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
| Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
| ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
| Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
| Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
| Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
| AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
| Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |